Changes in the gut microbiota of rats after exposure to the fungicide Mancozeb

• Published in: Toxicology and applied pharmacology Vol. 466; p. 116480
• Main Authors: Pezzini, Marina Ferri, Rampelotto, Pabulo Henrique, Dall'Agnol, Juliana, Guerreiro, Gabriel Tayguara Silveira, Longo, Larisse, Suarez Uribe, Nelson D., Lange, Elisa Carolina, Álvares-da-Silva, Mário Reis, Joveleviths, Dvora
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-05-2023
• Subjects: 16S rRNA; Animals; Experimental model; Feces - microbiology; Fungicides, Industrial; Gastrointestinal Microbiome; Male; Microbiome; Network analysis; Pesticide; Rats; Rats, Sprague-Dawley; RNA, Ribosomal, 16S - genetics; Toxicity; PCoA; LEfSe; 16S rRNA; OTU; Pesticide; MZ2; Toxicity; MZ1; Network analysis; Experimental model; LDA; Microbiome
• ISSN: 0041-008X; 1096-0333
• DOI: 10.1016/j.taap.2023.116480

Mancozeb is a fungicide commonly used in pest control programs, especially to protect vineyards. Its toxicity has already been evidenced in several studies. However, its influence on the composition and diversity of the gut microbiota remains unknown. In this work, the adverse impact of Mancozeb on the intestinal microbiota was investigated using a rodent model. Adult male Sprague Dawley rats were randomized into three groups: Control (standard diet), MZ1 (Mancozeb dose: 250 mg/kg bw/day), and MZ2 (Mancozeb dose: 500 mg/kg bw/day). After 12 weeks of experiment, animals were euthanized, and feces present in the intestine were collected. After fecal DNA extraction, the V4 region of the 16S rRNA gene was amplified followed by sequencing in an Ion S5™ System. Alpha and beta diversity analysis showed significant differences between Control and Mancozeb groups (MZ1 e MZ2), but no difference between MZ1 and MZ2 was observed. Seven genera significantly increased in abundance following Mancozeb exposure, while five genera decreased. Co-occurrence analyses revealed that the topological properties of the microbial networks, which can be used to infer co-occurrence interaction patterns among microorganisms, were significantly lower in both groups exposed to Mancozeb when compared to Control. In addition, 23 differentially abundant microbial metabolic pathways were identified in Mancozeb-treated groups mainly related to a change in energy metabolism, LPS biosynthesis, and nucleotide biosynthesis. In conclusion, the exposure to Mancozeb presented side effects by changing the composition of the microbiota in rats, increasing bacterial diversity regardless of the dose used, reducing the interaction patterns of the microbial communities, and changing microbial metabolic pathways.
[Display omitted]
•Mancozeb increased bacterial diversity regardless of the dose used.•Mancozeb significantly increased the abundance of seven microbial taxa.•Mancozeb reduced the microbial co-occurrence network complexity.•Mancozeb changed energy metabolism as well as LPS and nucleotide biosynthesis.